Reinfection withEhrlichia chaffeensisin a Liver Transplant Recipient
نویسندگان
چکیده
منابع مشابه
Reinfection with Ehrlichia chaffeensis in a liver transplant recipient.
Human monocytic ehrlichiosis is an emerging infection caused by Ehrlichia chaffeensis, but reinfection with this agent has not been described. We report a case of reinfection with E. chaffeensis after a 2-year interval in a 56-year-old liver transplant recipient with frequent tick attachments.
متن کاملRelapsing polychondritis in a liver transplant recipient
RATIONALE Relapsing polychondritis (RP) is a multisystemic, progressive disease of unknown etiology characterized by recurrent inflammation and progressive cartilage destruction. It can involve all types of cartilage including ears and nose, tracheobronchial tree, joints, and any other tissue rich in proteoglycans such as heart, eyes, and blood vessels. Recurrent chondritis can be life-threaten...
متن کاملParacoccidioidomycosis in a liver transplant recipient.
Paracoccidioidomycosis is a granulomatous systemic mycosis that is endemic in Latin America; it is an extremely rare infection following solid organ transplantation. In this study, we describe the first report of disseminated paracoccidioidomycosis in a 3-year-old girl who underwent liver transplantation 2 years previously. The radiologic diagnosis and patient follow-up are described. In additi...
متن کاملA liver transplant recipient with an infected explanted liver.
Figure 2. Magnification ( 400) of figure 1, showing the eggs within the uterus of Clonorchis sinenis. Figure 1. Micrograph of a liver biopsy specimen from the patient’s explanted liver showing Clonorchis sinensis in intrahepatic biliary ducts, with labeled structures. A, Intrahepatic bile duct; B, C. sinensis uterus filled with eggs; C, seminal receptacle; D, cecum; E, vitellaria. (Hematoxylin ...
متن کاملPrimary care of the liver transplant recipient.
Chronic rejection of liver graft is an insidious process. Major immunosuppression medications such as tacrolimus, cyclosporin, and sirolimus have dose-related toxicity and narrow therapeutic windows. Certain drugs can affect metabolism of calcineurin inhibitors. Primary care physicians should be vigilant for any unusual opportunistic infection in liver transplant recipients. The quality of life...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2002
ISSN: 1058-4838,1537-6591
DOI: 10.1086/340523